Hospital superbug debugged

An international team of scientists led by Monash University researchers has uncovered how a common hospital bacterium becomes a deadly superbug that kills increasing numbers of hospital patients worldwide and accounts for an estimated $3.2 billion each year in health care costs in the US alone. Their findings appear October 13th in the Open Access journal PLoS Pathogens.

Team leader Dr Dena Lyras and lead author Dr Glen Carter, from the Monash University School of Biomedical Sciences, have linked a naturally occurring mutation in the microorganism Clostridium difficile to severe and debilitating diarrhoea in undergoing antibiotic therapy. These antibiotics destroy the 'good' bacteria in the gut, which allows this 'bad' bacterium to colonise the colon, where it causes bowel infections that are difficult to treat.

"This mutation effectively wipes out an inbuilt disease regulator, called anti-sigma factor TcdC, producing hypervirulent strains of C. difficile that are resistant to antibiotics and which have been found to circulate in Canada, the US, UK, Europe and Australia," Dr Lyras says.

The results suggest that carrying this mutation have the potential to produce more of the harmful toxins that cause disease in susceptible individuals - commonly patients aged 65 years or over.

Dr. Carter adds, "As we now have a better understanding of these strains, we can design new strategies to prevent, control and treat these infections."

Citation: Hospital superbug debugged (2011, October 13) retrieved 22 September 2019 from https://medicalxpress.com/news/2011-10-hospital-superbug-debugged.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Oct 13, 2011
Of course, if we stopped overusing antibiotics we'd find ourselves in this mess less often. Overuse of antibiotics (a) kills beneficial bacterial intestinal and gut flora and (b) promotes the development of antibiotic-resistant bacteria.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more